Valuation: GENFIT

Market Cap 66Cr 77Cr 62Cr 57Cr 106.62Cr 7.3TCr 108.29Cr 725.95Cr 284.86Cr 3.65TCr 287.28Cr 281.01Cr 12TCr P/E 2026 *
34.2x
P/E 2027 * 87.9x
Enterprise Value 61Cr 71Cr 57Cr 52Cr 98Cr 6.73TCr 100Cr 669.92Cr 262.87Cr 3.37TCr 265.1Cr 259.32Cr 11TCr EV / Sales 2026 *
6.1x
EV / Sales 2027 * 4.81x
Free-Float
86.88%
Yield 2026 *
-
Yield 2027 * -
1 day-3.07%
1 week-5.70%
Current month-9.69%
1 month-3.64%
3 months+55.40%
6 months+103.07%
Current year+151.47%
1 week 13.1
Extreme 13.1
14.66
1 month 12.34
Extreme 12.34
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
12/07/23 Buy

Director

5,300 0.0106%
07/07/23 Buy

Chief Executive Officer

10,000 0.0201%
07/07/23 Buy

Founder

10,000 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-3.07%-5.70%+297.60%+284.88% 77Cr
+1.29%+3.46%+6.43%+16.36% 5TCr
+0.89%+13.44%+491.34%+594.30% 4.44TCr
+3.08%+14.42%+24.57%+81.39% 4.08TCr
+1.38%+3.70%+34.54%+9.11% 3.98TCr
+0.85%+10.32%+21.22%+47.64% 3.25TCr
+0.08%+5.00% - - 1.69TCr
+1.99%+5.08%+38.70%+125.08% 1.68TCr
+0.34%+3.40%+5.39%+18.79% 1.4TCr
+3.56%+19.98%+86.23%+27.29% 1.32TCr
Average +1.04%+5.85%+111.78%+133.87% 2.69TCr
Weighted average by Cap. +1.47%+7.05%+108.09%+140.10%

Financials

2026 *2027 *
Net sales 10Cr 12Cr 9.37Cr 8.56Cr 16Cr 1.1TCr 16Cr 109.82Cr 43Cr 552.23Cr 43Cr 43Cr 1.84TCr 12Cr 14Cr 12Cr 11Cr 20Cr 1.37TCr 20Cr 135.96Cr 53Cr 683.68Cr 54Cr 53Cr 2.28TCr
Net income 2.29Cr 2.64Cr 2.14Cr 1.95Cr 3.68Cr 252.05Cr 3.74Cr 25Cr 9.84Cr 126.09Cr 9.92Cr 9.71Cr 419.96Cr 68L 78.55L 63.56L 58.09L 1.09Cr 75Cr 1.11Cr 7.45Cr 2.92Cr 37Cr 2.95Cr 2.89Cr 124.82Cr
Net Debt -5.11Cr -5.9Cr -4.78Cr -4.37Cr -8.23Cr -563.16Cr -8.36Cr -56Cr -22Cr -281.73Cr -22Cr -22Cr -938.33Cr -6.62Cr -7.64Cr -6.19Cr -5.65Cr -11Cr -729.02Cr -11Cr -73Cr -28Cr -364.71Cr -29Cr -28Cr -1.21TCr
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
10/26/10 €13.24 -3.07% 3,90,348
07/26/07 €13.66 -0.44% 1,65,976
06/26/06 €13.72 -2.56% 2,63,306
05/26/05 €14.08 -1.54% 2,37,999
04/26/04 €14.30 +1.85% 3,60,997
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
13.24EUR
Average target price
15.90EUR
Spread / Average Target
+20.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock